🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China flag China · Delayed Price · Currency is CNY
12.13
-0.38 (-3.04%)
Nov 20, 2026, 3:04 PM CST

SHE:002275 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,0252,0432,1922,1681,9541,739
Other Revenue
2.82.81.763.665.272.71
2,0272,0462,1942,1721,9601,741
Revenue Growth
-2.60%-6.76%1.03%10.81%12.55%11.15%
Cost of Revenue
502.25508.56610.47602.57574.37457.04
Gross Profit
1,5251,5371,5841,5691,3851,284
Selling, General & Admin
765.09817.78888.26920.66812.68722.13
Research & Development
149.36160.04173.29158.06217.04201.6
Other Operating Expenses
45.8722.2727.4229.8936.0932.8
Operating Expenses
1,0231,0231,0981,1091,070957.81
Operating Income
502.64514.23485.33460.41315.65326.37
Interest Expense
-18.87-19.86-13.84-16.36-20.24-18.21
Interest & Investment Income
17.4523.8734.433.1740.6439.8
Currency Exchange Gain (Loss)
0.350.350.19-0.08-3.590.57
Other Non Operating Income (Expenses)
1.28-0.22-0.250.05-0.58-1.23
EBT Excluding Unusual Items
502.85518.37505.84477.2331.89347.31
Gain (Loss) on Sale of Investments
9.947.714.651.190.161.77
Gain (Loss) on Sale of Assets
-0.310.1583.361.6731.2615.5
Asset Writedown
-17.71-0.73-0.86-0.17-1.02-8.12
Other Unusual Items
23.2111.4250.9538.3983.8972.61
Pretax Income
517.97536.93643.93518.28446.18429.06
Income Tax Expense
95.72103.79122.496.99116.6585.34
Net Income
422.25433.13521.53421.3329.53343.72
Net Income to Common
422.25433.13521.53421.3329.53343.72
Net Income Growth
-19.25%-16.95%23.79%27.85%-4.13%24.08%
Shares Outstanding (Basic)
586585586585588573
Shares Outstanding (Diluted)
586585586585588573
Shares Change
0.93%-0.11%0.15%-0.56%2.72%-0.74%
EPS (Basic)
0.720.740.890.720.560.60
EPS (Diluted)
0.720.740.890.720.560.60
EPS Growth
-19.99%-16.85%23.61%28.57%-6.67%25.00%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
580.64621.18506.16472.85466.4266.15
Free Cash Flow Per Share
0.991.060.860.810.790.47
Dividend Per Share
0.3000.5000.6000.6000.8000.900
Dividend Growth
-45.45%-16.67%0%-25.00%-11.11%125.00%
Gross Margin
75.23%75.14%72.17%72.25%70.69%73.75%
Operating Margin
24.79%25.14%22.12%21.20%16.11%18.74%
Profit Margin
20.83%21.17%23.77%19.40%16.81%19.74%
Free Cash Flow Margin
28.64%30.36%23.07%21.77%23.80%15.29%
EBITDA
578.04597.85579.92575.53412.21412.97
EBITDA Margin
28.51%29.22%26.43%26.50%21.03%23.72%
D&A For EBITDA
75.483.6294.59115.1296.5586.6
EBIT
502.64514.23485.33460.41315.65326.37
EBIT Margin
24.79%25.14%22.12%21.20%16.11%18.74%
Effective Tax Rate
18.48%19.33%19.01%18.71%26.15%19.89%
Revenue as Reported
2,0272,0462,1942,1721,9601,741
Advertising Expenses
-470.71530.36514.72361.86378.93